Biomarkers from Peri-Implant Crevicular Fluid (PICF) as Predictors of Peri-Implant Bone Loss: A Systematic Review
International Journal of Molecular Sciences · 06.02.2023 · 24 (4) · 3202
DOI: 10.3390/ijms24043202 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.02.2023. Verfasst von Francesca Delucchi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Sciences (DISC), Division of Prosthodontics and Implant Prosthodontics, University of Genoa, Largo R. Benzi 10, 16132 Genova, …. Hauptthemen laut MEDLINE: Peri-Implantitis, MicroRNAs, Dental Implants. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The aim of the present systematic review is to summarize current knowledge regarding the analysis of biomarkers extracted from peri-implant crevicular fluid (PICF) as predictors of peri-implant bone loss (BL). An electronic search was conducted on three databases, PubMed/MEDLINE, Cochrane Library, and Google Scholar, to find clinical trials published until 1 December 2022 suitable to answer the following focused question: in patients with dental implants, are biomarkers harvested from PICF predictive of peri-implant BL? The initial search yielded a total of 158 entries. After a full-text review and application of the eligibility criteria, the final selection consisted of nine articles. The risk of bias in included studies was assessed using the Joanna Briggs Institute Critical Appraisal tools (JBI). According to the present systematic review, some inflammatory biomarkers harvested from PICF (collagenase-2, collagenase-3, ALP, EA, gelatinase b, NTx, procalcitonin, IL-1β, and several miRNAs) seem to be correlated with peri-implant BL and may assist in the early diagnosis of pathological BL, that characterizes peri-implantitis. MiRNA expression demonstrated a predictive potential of peri-implant BL that could be useful for host-targeted preventive and therapeutic purposes. PICF sampling may represent a promising, noninvasive, and repeatable form of liquid biopsy in implant dentistry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgical Sciences (DISC), Division of Prosthodontics and Implant Prosthodontics, University of Genoa, Largo R. Benzi 10, 16132 Genova, Italy.
- Unit of Periodontology, Department of General Surgery and Surgical-Medical Specialties, University of Catania, 95124 Catania, Italy.
ORCID-Profile: Francesca Delucchi, Paolo Pesce, Gaetano Isola, Maria Menini
Zitieren
APA
Delucchi, F., Canepa, C., Canullo, L., Pesce, P., Isola, G., & Menini, M. (2023). Biomarkers from Peri-Implant Crevicular Fluid (PICF) as Predictors of Peri-Implant Bone Loss: A Systematic Review. International Journal of Molecular Sciences, 24(4), 3202. https://doi.org/10.3390/ijms24043202
Vancouver
Delucchi F, Canepa C, Canullo L, Pesce P, Isola G, Menini M. Biomarkers from Peri-Implant Crevicular Fluid (PICF) as Predictors of Peri-Implant Bone Loss: A Systematic Review. International Journal of Molecular Sciences. 2023;24(4):3202. doi:10.3390/ijms24043202
BibTeX
@article{Delucchi2023,
author = {Delucchi, Francesca and Canepa, Camilla and Canullo, Luigi and Pesce, Paolo and Isola, Gaetano and Menini, Maria},
title = {Biomarkers from Peri-Implant Crevicular Fluid (PICF) as Predictors of Peri-Implant Bone Loss: A Systematic Review},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {4},
pages = {3202},
doi = {10.3390/ijms24043202}
}
EUVIMED